C4 Therapeutics
PublicC4 Therapeutics is now publicly traded
The data on this page reflects C4 Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 6, 2020
Last Round
Follow-on Offering
Oct 17, 2025
Est. Valuation at Exit
$283M
Total Funding Raised
$855.56M
Company Overview
C4 Therapeutics is a biopharmaceutical company that develops targeted protein degradation therapies to treat cancer and other diseases.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
C4 Therapeutics Comparables
Compare C4 Therapeutics with similar companies based on industry and business-model similarity.
No public comparables are available for C4 Therapeutics. Request access to learn about comparables coverage.
Request accessC4 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Oct 17, 2025 | ||||
| Follow-on Offering | Jan 9, 2024 | ||||
| Private Placement | Jan 4, 2024 | ||||
| Follow-on Offering | Jun 21, 2021 | ||||
| IPO | Oct 6, 2020 | ||||
Debt | Jun 16, 2020 |
C4 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO, Follow-on Offering |
| Soleus Capital | Follow-on Offering |
| Bain Capital Life Sciences | Series B, Follow-on Offering |
| Janus Henderson Group | Series B |
| Taiwania Capital | Series B |
| RA Capital Management | Series B, Follow-on Offering |
| Perceptive Advisors | Debt, Series B |
C4 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access